Companies / Singapore With no national debt and the economy growing at 6.3% in 2006, according to BMI forecasts, Singapore is able to invest around US$25- US$30mn on average per year in stem cell research. This forms part...
Companies / Singapore Singapore has completed the first phase of its Biomedical Science (BMS) initiative, and is keen to push on to phase II, which will have government investment of US$1.4bn. Under the initial plans, which...
Companies / Singapore UK-based drugmaker GlaxoSmithKline (GSK) has indicated that in future it will be conducting more of its R&D in Asia, with Singapore and India looking like the company's favoured locations. The company...
Companies / Singapore Singapore's volatile pharmaceutical exports sector rose by 60% in September, according to United Overseas Bank (UOB), boosted by strong demand in Europe. Pharmaceuticals are a key growth driver of the...
Companies / Singapore Singapore-based healthcare group Parkway Holdings is expecting its clinics in India to start making profits in 2007, although its medical centres in Vietnam and China will continue to incur losses. Parkway...